Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04107766 · ClinicalTrials.gov registry record
NOLA (NeuWave Observational Liver Ablation) Registry
A clinical trial, sponsored by Ethicon.
- Terminated
- Registry status
- 1,254
- Enrollment target
NCT04107766: Clinical Trial study, sponsored by Ethicon.
NCT04107766 is a clinical trial that was terminated before completion, run by Ethicon. The registered enrollment target is 1,254 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04107766 was terminated before completion, sponsored by Ethicon.
- TERMINATED
- Registry status
- 1,254 participants
- Enrollment target
Study Summary
This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.
Primary Outcome
Technical Success is defined as ablation of the target lesion(s) according to the protocol and covered completely, with an adequate margin (that is, the ablation zone completely overlaps or encompasses the target lesion(s) plus an ablative margin), as defined by the performing physician who will make the assessment using CT, MRI, PET, US, and/or X-ray, immediately following the procedure.
Interventions
- DEVICE Microwave Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,254 participants |
| Start Date | 2020-01-15 |
| Est. Completion | 2025-06-18 |
Why NCT04107766 stopped before completion
NCT04107766 is an observational study that tracks outcomes without assigning an intervention. Its 1,254 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Microwave Ablation is the first listed.
NCT04107766 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04107766 about?
NCT04107766 is a clinical study titled "NOLA (NeuWave Observational Liver Ablation) Registry". This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.
What is the current status of trial NCT04107766?
This trial is currently terminated. The enrollment target is 1,254 participants. The study started on 2020-01-15. Estimated completion is 2025-06-18.
What interventions are being tested in trial NCT04107766?
The interventions under investigation include: Microwave Ablation (DEVICE).
Who is sponsoring clinical trial NCT04107766?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI